About Unilabs
Unilabs is a company based in Geneve (Switzerland) founded in 2000 was acquired by A P Moller Holding in December 2021. Unilabs has completed 8 acquisitions, including Adus Radiology, Alpha Medical and Biopath. Unilabs offers products and services including Laboratory Diagnostic Services, Imaging Diagnostic Services, and Pathology Diagnostic Services. Unilabs operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
- Headquarter Geneve, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Unilabs Limited
-
Annual Revenue
$19.01 M (USD)13as on Dec 31, 2022
-
Net Profit
-$3.35 M (USD)-129as on Dec 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
$137.56 K (USD), Grant
Feb 01, 2016
-
Investors
Apax Partners
& 4 more
-
Employee Count
Not available
-
Investments & Acquisitions
Adus Radiology
& 7 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Unilabs
Unilabs offers a comprehensive portfolio of products and services, including Laboratory Diagnostic Services, Imaging Diagnostic Services, and Pathology Diagnostic Services.
Offers lab testing and analysis for medical diagnostics.
Provides radiology and imaging exams for patient care.
Delivers advanced pathology analysis for health assessments.
People of Unilabs
Unlock access to complete
Unlock access to complete
Funding Insights of Unilabs
Investors in Unilabs
Unilabs has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Apax Partners, Capio and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Equity investments are focused on tech, services, and consumer sectors.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Unilabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Unilabs
Unilabs has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Adus Radiology, Alpha Medical and Biopath.
Investment portfolio details for Unilabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Medical research laboratories are provided by Polibio.
|
Locked | Locked | 2021 | Locked | |
|
Chain of medical laboratories
|
Locked | Locked | 2014 | Locked | |
|
Online platform to find diagnostic labs
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Unilabs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Unilabs
Detailed financials for Unilabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Unilabs Comparisons
Peer comparison for Unilabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Unilabs
Unilabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
Detailed competitors of Unilabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Unilabs
Complete news archive for Unilabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unilabs
Unilabs was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Unilabs is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Annual revenue of Unilabs is $19.01M as on Dec 31, 2022.
Unilabs is a leading diagnostic services company and operates more than 120 laboratories and 44 radiology units in Denmark, Finland, France, Italy, Norway, Portugal, Russia, Spain, Sweden, Switzerland, and the United Kingdom. Unilabs customers are public and private healthcare providers, county councils, the general public, insurance companies, the pharmaceutical industry, and CROs. Unilabs supplies medical laboratory services within laboratory medicine, genetic testing, medical imaging, cellular pathology, reproductive medicine, drug development services, and clinical trials.
Unilabs's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Unilabs offers Laboratory Diagnostic Services, Imaging Diagnostic Services, and Pathology Diagnostic Services.
Unilabs has made 8 acquisitions, including Adus Radiology, Alpha Medical, and Biopath.
Unilabs has 5 investors. Key investors include Apax Partners, Capio, European Union, Nordic Capital, and A P Moller Holding.